Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Gains from Sales and Divestitures (2019 - 2025)

Verastem (VSTM) has 7 years of Gains from Sales and Divestitures data on record, last reported at $468885.0 in Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures rose 312.09% year-over-year to $468885.0; the TTM value through Dec 2025 reached $468885.0, up 312.09%, while the annual FY2025 figure was $468885.0, 312.09% up from the prior year.
  • Gains from Sales and Divestitures reached $468885.0 in Q4 2025 per VSTM's latest filing, down from $642000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $5.0 million in Q4 2021 and bottomed at $14279.0 in Q1 2024.
  • Average Gains from Sales and Divestitures over 5 years is $538039.9, with a median of $114062.0 recorded in 2024.
  • Peak YoY movement for Gains from Sales and Divestitures: crashed 96.56% in 2023, then surged 1665.78% in 2025.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $5.0 million in 2021, then crashed by 82.56% to $876829.0 in 2022, then plummeted by 96.56% to $30128.0 in 2023, then surged by 277.66% to $113782.0 in 2024, then surged by 312.09% to $468885.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Sales and Divestitures were $468885.0 in Q4 2025, $642000.0 in Q3 2025, and $591731.0 in Q2 2025.